Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

373.00
Delayed Data
As of Mar 24
 +7.98 / +2.19%
Today’s Change
325.35
Today|||52-Week Range
452.96
+1.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
AssetsCash604.2M646.5M920.4M535.2M
 
 
 
 
 
Short Term Investment Cash-204.9M42.3M273.9M-385.2M
 
 
 
 
 
Cash & Short Term Investments849.2M1.0B1.4B1.0B
 
 
 
 
 
 
ReceivablesReceivables1.9B1.8B1.6B1.6B
 
 
 
 
 
 
InventoriesInventories303.3M316.1M345.6M399.4M
 
 
 
 
 
 
Current AssetsOther Current Assets115.7M96.0M103.8M130.5M
 
 
 
 
 
Current Assets3.1B3.2B3.5B3.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------2.5B
 
 
Depreciation-------425.5M
 
 
Other Assets5.8M6.7M20.7M20.3M
 
 
 
 
 
Total Assets5.9B6.2B6.8B7.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable120.6M101.7M124.5M135.0M
 
 
 
 
 
Short Term Debt0.000.000.00127.3M
 
 
Accrued Expenses375.9M373.1M295.2M355.3M
 
 
 
 
 
Other Current Liabilities562.4M565.0M541.5M590.4M
 
 
 
 
 
Other Liabilities919.7M951.6M961.2M1.2B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt362.2M361.5M382.2M351.6M
 
 
 
 
 
Deferred Taxes-543.7M-626.2M-655.6M-825.3M
 
 
 
 
 
Other Liabilities121.0M119.5M135.7M100.4M
 
 
 
 
 
Total Liabilities2.1B2.1B2.3B2.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity3.8B4.1B4.5B4.4B
 
 
 
 
 
Total Shareholder Equity3.8B4.1B4.5B4.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding105.0M105.3M105.5M106.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.